| • |
To be dutiful in placing the interests of the Company’s shareholders first and before their own;
|
| • |
all personal securities transactions must be conducted consistent with this 1940 Act Code of Ethics and in such a manner as to avoid any actual or potential conflict of interest or
any abuse of an individual's position of the Company and responsibility; and
|
| • |
adhere to the fundamental standard that Access Persons shall not take inappropriate advantage of their position.
|
| • |
employ any device, scheme or artifice to defraud the Company;
|
| • |
make any untrue statement of a material fact to the Company or fail to state a material fact necessary in order to make the statements made to the Company, in light of the
circumstances under which they were made, not misleading;
|
| • |
engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon the Company; or
|
| • |
engage in any manipulative practice with respect to the Company, in connection with the purchase or sale (directly or indirectly) by such Access Person of a security "held or to be
acquired" by the Company.
|
| • |
Direct obligations of the Government of the United States;
|
| • |
Bankers’ acceptances, bank certificates of deposit, commercial paper and high-quality short-term debt instruments, including repurchase agreements; and
|
| • |
Shares issued by open-end funds (excluding open-end exchange traded funds).
|
| 1. |
Any Covered Security which, within the most recent fifteen (15) days:
|
| • |
Is or has been held by the Company; or
|
| • |
Is being or has been considered by the Company or its Adviser for purchase by the Company;and
|
| • |
Any option to purchase or sell, and any security convertible into or exchangeable for, a Covered Security.
|
| 1. |
Restrictions on personal securities transactions by Access Persons, other than Restricted Directors.
|
| a. |
Except as provided below, no Access Person who is not a Restricted Director may buy or sell Covered Securities for his or her personal portfolio or the portfolio of a member of his
or her immediate family without obtaining authorization from the CCO of the Adviser prior to effecting such security transaction.
|
| b. |
Pre-clearance approval under paragraph (a) will expire at the close of business on the trading day after the date on which the authorization is received, and the Access Person is
required to renew clearance for the transaction if the trade is not completed before the authority expires.
|
| c. |
No clearance will be given to an Access Person other than a Restricted Director to purchase or sell any Covered Security (1) on a day when the Company has a pending "buy" or"sell"
order in that same Covered Security until that pending "buy" or "sell" order is executed or withdrawnor (2) when the Company CCO has been advised by the Adviser that the same Covered Security is being considered for purchase or sale for any
portfolio of the Company.
|
| d. |
The pre-clearance requirement contained above shall not apply to the following securities ("Exempt Securities"):
|
| • |
Securities that are not Covered Securities;
|
| • |
De Minimis Securities;
|
| • |
Securities purchased or sold in any account over which the Access Person has no direct or indirect influence or control;
|
| • |
Securities purchased or sold in a transaction which is non-volitional on the part of either the Access Person or the Company;
|
| • |
Securities acquired as a part of an Automatic Investment Plan;
|
| • |
Securities acquired upon the exercise of rights issued by an issuer pro rata to all holders of a class of its securities, to the extent such rights were acquired from such issuer,
and sales of such rights so acquired; and
|
| • |
Securities which the Company's funds are not permitted to purchase under the investment objectives and policies set forth in the Company's then current prospectus(es) under the
Securities Act or the Company's registration statement on Form N-2, provided that prior to a transaction by an Access Person such securities have been approved for inclusion in a list of securities which are not permissible for purchase by
the Company.
|
| e. |
The pre-clearance requirement contained shall apply to all purchases of a beneficial interest in any security through an Initial Public Offering or a Limited Offering by any Access
Person who is also classified as Investment Personnel. A record of any decision and the reason supporting such decision to approve the acquisition by investment personnel of Initial Public Offerings or Limited Offerings shall be made by the
CCO.
|
| 2. |
Restrictions on personal securities transactions by Restricted Directors.
|
| a. |
The securities pre-clearance requirement detailed above shall only apply to a Restricted Director if he or she knew or, in the ordinary course of fulfilling his or her official
duties as a director, should have known, that during the 15-day period before the transaction in a Covered Security (other than an Exempt Security) or at the time of the transaction that the Covered Security purchased or sold by him or her
other than an Exempt Security was also purchased or sold by theCompany or considered for the purchase or sale by the Company.
|
| b. |
If the pre-clearance provisions of the preceding paragraph apply, no clearance will be given to a Restricted Director to purchase or sell any Covered Security (1) on a day when any
portfolio of the Company has a pending "buy" or "sell" order in that same Covered Security until that order is executedor withdrawn or (2) when a CCO has been advised by the Adviser that the same Covered Security is being considered for
purchase or sale for any portfolio of the Company.
|
| • |
the name of the broker, dealer or bank with whom the Access Person has established the account;
|
| • |
the date the account was established;
|
| • |
the date that the report is submitted by the Access Person.
|
| • |
Each of these accounts is required to furnish duplicate confirmations and statements to the Chief Compliance Officer. Such statements and confirms as an Access Person of the
Company may be sent to the Adviser.
|
| • |
The date of the transaction, the title, and as applicable, the exchange ticker symbol or CUSIP number, interest rate and maturity date, number of shares, and the principal amount
of each Covered Security;
|
| • |
The nature of the transaction (i.e., purchase, sale or any other type of acquisition or disposition),
|
| • |
The price of the Covered Security at which the transaction was effected
|
| • |
The name of the broker, dealer, or bank with or through whom the transaction was effected; and
|
| • |
The date the Access Person submits the report.
|
| • |
any transaction that appears to evidence a possible violation of this 1940 Act Code of Ethics; and
|
| • |
apparent violations of the reporting requirements stated herein.
|
|
Printed Name:
|
||
|
Signature:
|
||
|
Date:
|
||